Education
About Us
Working with TipRanks
Follow Us
Cresco Labs OTC (TSE:CL)
:CL
Earnings Data
Report Date
Aug 08, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.04Last Year’s EPS
-0.15Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 30, 2025
|% Change Since: -19.35%
|Next Earnings Date:Aug 08, 2025
Earnings Call Sentiment|Neutral
Cresco Labs demonstrated strong cash flow and strategic market expansion, maintaining leadership in key markets and innovating product offerings. However, revenue declines, margin pressures, and challenges from regulatory transitions present concerns. Overall, the highlights are significant but balanced by notable challenges.Company Guidance
In the first quarter of 2025, Cresco Labs delivered $166 million in revenue, aligning with their guidance by strategically managing their wholesale accounts and reducing accounts receivable exposure. The company achieved an adjusted gross profit of $82 million and an adjusted EBITDA of $36 million. Their efficiency initiatives helped mitigate lower operating leverage and maintain margins, resulting in $30 million in operating cash flow and a cash balance of $162 million, marking the highest in three years. Cresco Labs continued to focus on strategic growth, prioritizing depth over breadth in market expansion, and maintained their leadership position in branded wholesale products, holding the number one market share in Illinois and Pennsylvania. They also reported that Sunnyside dispensaries outperformed, generating approximately 25% more revenue per store than the state average. Looking ahead, they anticipate modest revenue decline in Q2 due to Illinois' seed-to-sale system conversion, with the expectation of sales normalization in future quarters.Strong Cash Flow and Balance Sheet
Cresco Labs generated $30 million in operating cash flow and ended the quarter with $162 million in cash, marking the highest cash balance in the past three years.
Strategic Market Expansion
Cresco Labs is expanding its footprint by opening new dispensaries in Pennsylvania and Ohio, and building a major cultivation facility in Kentucky, demonstrating a focus on long-term growth in high-margin states.
Leading Market Share in Key States
Cresco Labs retained number one market share positions in Illinois and Pennsylvania and maintained a top-five position across all limited licensed wholesale markets.
Innovation in Product Offerings
Cresco Labs introduced nearly 40 unique new flavors and next-generation premium vapes, along with new hardware and formats for high supply vapes and edibles.
Strong Retail Performance
Sunnyside dispensaries generated approximately 25% more revenue per store than the state average, with 80% of transactions coming from Sunnyside.shop.
TSE:CL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:CL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 30, 2025 | C$0.93 | C$0.84 | -9.68% |
Mar 12, 2025 | C$1.07 | C$1.06 | -0.93% |
Nov 08, 2024 | C$1.75 | C$1.73 | -1.14% |
Aug 08, 2024 | C$1.97 | C$2.23 | +13.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cresco Labs OTC (TSE:CL) report earnings?
Cresco Labs OTC (TSE:CL) is schdueled to report earning on Aug 08, 2025, TBA Not Confirmed.
What is Cresco Labs OTC (TSE:CL) earnings time?
Cresco Labs OTC (TSE:CL) earnings time is at Aug 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:CL EPS forecast?
TSE:CL EPS forecast for the fiscal quarter 2025 (Q2) is -0.04.